Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study
Giuseppe Curigliano, Miguel Martín, Komal Jhaveri, J. Thaddeus Beck, Giampaolo Tortora, Nicola Fazio, Michela Maur, Richard Hubner, Harald Lahner, V Donnet, Olga Ajipa, Zheng Li, Lars Blumenstein, Fabrice André
Topics & Concepts
MedicineEverolimusMucositisInternal medicineExemestaneStomatitisOncologyPharmacodynamicsPharmacologyPharmacokineticsGastroenterologyBreast cancerCancerChemotherapyAromatasePI3K/AKT/mTOR signaling in cancerSphingolipid Metabolism and SignalingParathyroid Disorders and Treatments